Daglutril is an orally active, mixed neutral endopeptidase/endothelin converting enzyme inhibitor under development for the treatment of essential hypertension and congestive heart failure. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Daglutrilo and Daglutrilum. Its PubChem CID is 3038505.
Daglutril
| CAS No | 182821-27-8 |
|---|---|
| Molecular Formula | C31H38N2O6 |
| Molecular Weight | 534.6 g/mol |
| Synonyms | 2-[(3S)-3-[[1-[(2R)-2-ethoxycarbonyl-4-phenylbutyl]cyclopentanecarbonyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Daglutril is an orally active, mixed neutral endopeptidase/endothelin converting enzyme inhibitor under development for the treatment of essential hypertension and congestive heart failure.
The listed CAS number is 182821-27-8.
The listed molecular formula is C31H38N2O6.
The listed molecular weight is 534.6 g/mol.
2-[(3S)-3-[[1-[(2R)-2-ethoxycarbonyl-4-phenylbutyl]cyclopentanecarbonyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid.
The source lists Daglutrilo and Daglutrilum.